N/A
Manufactured by Organon LLC
19,228 FDA adverse event reports analyzed
Last updated: 2026-04-14
DESLORATADINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Organon LLC. The most commonly reported adverse reactions for DESLORATADINE include DRUG INEFFECTIVE, FATIGUE, NAUSEA, DYSPNOEA, HEADACHE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DESLORATADINE.
Out of 10,250 classified reports for DESLORATADINE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 19,228 FDA FAERS reports that mention DESLORATADINE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, FATIGUE, NAUSEA, DYSPNOEA, HEADACHE, DIARRHOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Organon LLC in connection with DESLORATADINE. Always verify the specific product and NDC with your pharmacist.